autologous human schwann cells
Cell therapyexperimental
Clinical trial activity
7 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01739023)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous human schwann cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05541250 | Phase 1 | Dec 20, 2022 | Department of Defense, University of Miami |
| NCT03999424 | Phase 1 | Sep 1, 2019 | The Miami Project to Cure Paralysis, University of Miami |
| NCT02510079 | N/A | Jul 15, 2015 | The Miami Project to Cure Paralysis, University of Miami |
| NCT02480777 | N/A | Jun 21, 2015 | The Miami Project to Cure Paralysis, University of Miami |
| NCT02354625 | Phase 1 | Jan 1, 2015 | The Miami Project to Cure Paralysis, University of Miami |
| NCT01739023 | Phase 1 | Nov 1, 2012 | The Miami Project to Cure Paralysis, University of Miami |
| NCT04465929 | N/A | — | University of Miami |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Miami | Academic/Hospital | 7 | 7 | 2 | 2012 |
| The Miami Project to Cure Paralysis | Academic/Hospital | 5 | 0 | 2 | 2012 |
| Department of Defense | Government | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1